Translational Science BioCore Shared Resource
Translational Science BioCore Shared Resource
批准号:
10456694
负责人:
Kristina A. Matkowskyj
金额:
$7.23万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-25 至 2023-05-31
关键词:
AddressBloodBody FluidsCancer BurdenCancer Center Support GrantCell LineClinicalClinical DataClinics and HospitalsCodeCollectionCommunitiesComprehensive Cancer CenterConfidentiality of Patient InformationConsultDNADevelopmentDiseaseEnsureFormalinFreezingFrozen SectionsFundingHistopathologyHumanHuman bodyImmunohistochemistryIn Situ HybridizationInfrastructureInstitutional Review BoardsLaboratoriesLinkMissionMolecularMolecular AnalysisParaffin EmbeddingPathologistPathologyPatientsProceduresProteinsProtocols documentationRNAReproducibilityResearchResearch PersonnelResource SharingSafetyServicesSlideSpecific qualifier valueSpecimenTimeTissue EmbeddingTissue MicroarrayTissue StainsTissuesTranslational ResearchUnited States National Institutes of HealthWisconsinbiobankclinically relevantdigital pathologydisorder subtypehuman tissueimaging platforminnovationinstrumentationlaser capture microdissectionliquid crystal polymermeetingsmembermolecular pathologymolecular phenotypeneoplasticoperationpathology imagingprospectivetissue archivetranslational cancer researchtranslational goal
中文摘要
项目摘要/摘要
翻译科学生物核心(TSB)的使命是促进基础和翻译癌症研究
通过为UWCCC成员提供全面的服务,使其能够实现蜂窝和分子
人源性生物旋毛虫的特征。目标1是收集和分发人类来源的
生物群落。TSB在机构审查委员会(IRB)的批准下运营,以前瞻性地收集、存储和
分发我们医院内接受治疗的患者的各种人体组织和体液,以及
诊所。已经建立了标准的操作程序,以确保收集的生物检疫物质符合
指定的质量参数。TSB是由IRB授权作为“诚实的经纪人”,并提供
调查人员具有所需的临床和人口统计学注释,其编码方式可保护
病人保密。TSB还为UWCCC提供生物菌种收集、处理和存储服务
指导项目特定的、IRB批准的协议的成员。目标2是构建和传播疾病
特定组织微阵列(TMA)。TSB病理学家检查档案组织块以很好地识别标本
适合包含在每个疾病特定的TMA中,然后由TSB工作人员构建。每个TMA都是完全
带有相关临床数据的注释,并按照适当的机构分发给UWCCC成员
复习一下。目标3是提供分子病理学和成像专业知识和基础设施。TSB病理学家和
专家工作人员与UWCCC成员协商,指导以下研究的开发、实施和解释
利用人类衍生的生物标本,还在各种分子领域提供广泛的专业知识和服务
病理学应用,包括染色组织切片的形态计量分析,定量分析
特定的分子表型,激光捕获显微切割,原位杂交,免疫组织化学。
TSB拥有每项服务所需的最先进的仪器;例如,Vectra和Nuance
多光谱成像平台和Aperio数字病理全幻灯片扫描仪。TSB还提供了一个
关于人类衍生生物标本的基本组织病理学支持服务分类。最后,TSB提供了一个
细胞系认证服务,以帮助UWCCC成员满足NIH对科学严谨性和
再现性。对UWCCC的影响:TSB在本届CCSG期间取得了许多值得注意的里程碑
资金周期。在此期间,我们增加了收集和分发生物旋毛虫的数量,
支持的方案和试验的数量,以及所服务的UWCCC成员的数量。我们不断地
评估UWCCC研究界的需求,并努力及时解决所有确定的需求
举止。我们加强了现有的服务,并增加了新的服务,使我们的会员能够
开展创新研究,推进UWCCC的使命。
英文摘要
PROJECT SUMMARY / ABSTRACT
The mission of the Translational Science Biocore (TSB) is to facilitate basic and translational cancer research
by providing UWCCC members with a comprehensive array of services that enable cellular and molecular
characterization of human derived biospecimens. Aim 1 is to collect and distribute human derived
biospecimens. TSB operates with Institutional Review Board (IRB) approval to prospectively collect, store, and
distribute a wide variety of human tissues and body fluids from patients being treated within our hospitals and
clinics. Standard Operating Procedures have been established to ensure the collected biospecimens meet
specified quality parameters. TSB is authorized by the IRB to serve as an ‘honest broker’ and provide
investigators with needed clinical and demographic annotations that are coded in a manner that protects
patient confidentiality. TSB also provides biospecimen collection, processing, and storage services to UWCCC
members who direct project specific, IRB-approved protocols. Aim 2 is to construct and distribute disease
specific tissue microarrays (TMAs). TSB pathologists review archival tissue blocks to identify specimens well
suited for inclusion in each disease specific TMA, which is then constructed by TSB staff. Each TMA is fully
annotated with relevant clinical data and is distributed to UWCCC members following appropriate institutional
review. Aim 3 is to provide molecular pathology and imaging expertise and infrastructure. TSB pathologists and
expert staff consult with UWCCC members to guide development, conduct, and interpretation of studies that
utilize human derived biospecimens and also provide broad expertise and services in a variety of molecular
pathology applications, including morphometric analysis of stained tissue sections, quantitative analyses of
specific molecular phenotypes, laser capture microdissection, in situ hybridization, and immunohistochemistry.
TSB houses the state-of-the-art instrumentation required for each of these services; e.g., Vectra and Nuance
multispectral imaging platforms and Aperio digital pathology whole slide scanner. TSB also provides an
assortment of basic histopathology support services on human derived biospecimens. Finally, TSB provides a
cell line authentication service to assist UWCCC members in meeting NIH requirements for scientific rigor and
reproducibility. Impact on UWCCC: TSB has achieved many noteworthy milestones during the current CCSG
funding cycle. During this period, we have increased the volumes of biospecimens collected and distributed,
the numbers of protocols and trials supported, and the number of UWCCC members served. We continuously
evaluate the needs of the UWCCC research community and strive to address all identified needs in a timely
manner. We have enhanced our existing services and have added new services to enable our members to
perform innovative research that advances the UWCCC mission.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Pathology and Data Analysis Core (TPDAC)
-
批准号:10707115
-
项目类别:
-
资助金额:$17.1万
-
财政年份:2022
-
负责人:Kristina A. Matkowskyj
-
依托单位:
Translational Pathology and Data Analysis Core (TPDAC)
-
批准号:10519077
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2022
-
负责人:Kristina A. Matkowskyj
-
依托单位:
Translational Science Biocore
-
批准号:10626523
-
项目类别:
-
资助金额:$2.78万
-
财政年份:1997
-
负责人:Kristina A. Matkowskyj
-
依托单位:
Translational Science BioCore Shared Resource
-
批准号:9923025
-
项目类别:
-
资助金额:$9.08万
-
财政年份:--
-
负责人:Kristina A. Matkowskyj
-
依托单位:
海外基金